Please login to the form below

Not currently logged in
Email:
Password:

Akcea Pharma

This page shows the latest Akcea Pharma news and features for those working in and with pharma, biotech and healthcare.

Despite FDA concerns, Akcea rare disease drug clears FDA panel

Despite FDA concerns, Akcea rare disease drug clears FDA panel

Despite FDA concerns, Akcea rare disease drug clears FDA panel. FDA now set to deliver final verdict by 30 August. ... Akcea Pharma has moved a step closer to commercialising Waylivra, a drug for rare disorder familial chylomicronemia syndrome (FCS),

Latest news

  • Novartis boosts cardiovascular pipeline with $1bn Ionis deal Novartis boosts cardiovascular pipeline with $1bn Ionis deal

    The new agreement with Ionis subsidiary Akcea Pharma gives Novartis an option to license the two lipoprotein-targeting drugs, which are in early-stage clinical development. ... Novartis is also expected to make a further equity investment of $50m in the

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics